Global Shipping
B2B

IPL After a Hair Transplant: What to Tell Patients

After a hair transplant, IPL on the treated scalp waits for the clinic to clear it. Other body areas are the surgeon call, not the instruction manual.

i
Article author iShine Team

Citable Summary

What is this article about?

After a hair transplant, IPL should not be used on the treated scalp area until the clinic clears it, because the grafted follicles and the healing skin are not a candidate area. Use on other body areas is a separate question that depends on medication, healing and the surgeon's protocol. Clinics should give patients the boundary in writing at discharge, because the patient will otherwise read the device manual and answer the question themselves.

IPL After a Hair Transplant: What to Tell Patients

Short answer: the grafted area and the donor area wait for the clinic to clear them, and stay out of use for the whole healing window. Keeping clear of the surgical area is a necessary action, and the requirement goes further than that: for the first weeks the boundary between grafted and untreated skin is hard to see, because crusting, redness and new growth all blur it, so the clinic draws that line and a patient who estimates it is guessing. Whether another body area can be treated depends on the healing stage, the medication in the patient’s system and her individual response. That judgement belongs to her doctor. This article sets out what she should leave the clinic holding, and whom to ask.

Why the manual will not answer it

A device manual states who should not use the device in general terms. It does not know that this patient had grafts placed three weeks ago, what medication she is on, or how her donor area is healing.

When the manual is silent on a specific case, patients fill the gap with a search result. That is how a two-month-old transplant ends up under a home device.

The two zones

AreaWho decidesWhy
Grafted areaClinicGraft survival is a clinical question, and the clinic draws the boundary. A patient estimating that boundary is guessing.
Donor area, back of the headClinicIt is a wound in its own right. Patients leave it out because nothing was planted there.
Rest of the bodyClinic, judged per personAntibiotics, painkillers, anticoagulants, photosensitising drugs, a keloid history and an active infection act on the person. The leg can be an unsafe site on a body that would take treatment elsewhere.

This table divides responsibility. All three rows name the same judge, and each row gives a different reason: two of them are wounds, and the third is the patient’s own state.

What to hand over at discharge

One page, in the patient’s language, using the clinic’s wording:

  • The treated area is excluded until the follow-up date.
  • The follow-up date, written as a calendar date. A phrase like “when healed” gives the patient nothing to check.
  • Which medications slow healing or make skin photosensitive, and so delay any light-based treatment.
  • Who to ask, by role, if a device seller says otherwise.

That last line is the one patients use. A seller will not overrule a named person on a page.

Why clinics should care commercially

A patient who damages a graft with a home device blames the transplant. The clinical cost lands on the clinic that did the work, long after the aftercare conversation was skipped because it felt like a sales moment.

One printed page is cheaper than that conversation happening later, badly.

What we do, and what we do not

We manufacture home IPL devices and we state the general contraindications in the manual and on the box. We do not give clinical advice, we do not clear a patient for use, and we do not write a clinic’s aftercare protocol.

If you want the general contraindication list as a starting point, who should not use IPL is the public version. For the timing rules patients most often get wrong, the aftercare article covers the 48-hour windows.

What you will have to justify to the clinic owner

A one-page discharge instruction looks like admin. The case for it is three numbers the clinic already has.

Post-procedure enquiries: how many patients call within ninety days asking about hair removal or light devices. Each call is time a coordinator spends, and each one is a question the clinic could have answered at discharge.

Revision consultations: how many of those calls turn into a graft concern that turns out to be unrelated to the procedure. The clinic pays for that consultation either way.

Complaint cost: a conversation about a damaged graft area starts with the clinic. The device maker hears about it later, if at all. Put the clinic’s own hourly cost against the print run of a page.

How to say it without sounding defensive

“Read this as a list of things to avoid with a device we did not sell you. It says nothing about the quality of the work.”

That framing keeps the page in the aftercare pack. A legal disclaimer gets ignored. The clinics that use it report the same thing: patients read a page that names a date, and skip a page that says “consult your doctor”.

If the clinic decides to stock devices

Then the discharge page has to name the device as well as the category. A patient told “no light devices” while holding a box she just bought has been told nothing.

Write the page with the product in front of you: the treatment areas, the schedule, and the follow-up date where the conversation reopens. One page, one date, one person to ask.

That is the difference between a clinic that sells devices and one that sells devices and then manages the consequences. The platforms a clinic shelf can carry are on the products page, and if the clinic wants its own label on them, the private label terms state the minimum order, the price band and the tooling rules.

The one thing to check on the device

If a patient brings her own device to the consultation, ask her to show you the manual page that lists contraindications. Most manuals list tattoos, medication and broken skin. Few name a recent transplant, which is exactly why the clinic’s own page has to.

That check takes a minute and it tells you whether the patient has read anything at all. It also tells you which advice she has already been given, which is the part you cannot see from your side of the table.

Where the detail comes from

  • Lasers Surg Med, 2023 — an adverse-event assessment of a home-use IPL device.
  • CIE S 009 / IEC 62471 — the photobiological safety standard every IPL lamp is measured against.
  • UK MHRA — the regulator that classifies these devices and polices claims in Great Britain.

Need a project-specific answer?

Talk to our manufacturing team

Contact the team to discuss your market, volume, compliance needs, and product direction.

Last updated

Did you find this article helpful?

Related articles

Continue reading

+86-15900283962
Chat on WeChat — get a reply within 10 minutes